Skip to content
Biodatica
Start free

This week

The week in pre-ticker biotech

What moved in the last seven days, straight from the graph: grants awarded, trials registered and advanced, patents granted, raises filed. Every line links to the company and to the public filing behind it. Listed companies are left out on purpose; this page is about the window before the ticker.

Events this week
738

Dated by the filer, not by our crawl.

New companies
6+

Entered the graph in the last seven days.

Biggest disclosed raise
—

No Form D with a disclosed amount this week.

The moves that mattered

Ranked by event weight — a phase advance outranks a grant renewal however loud either one was. One line per company.

  1. Excyte Biopharma Ltdmomentum 72

    Phase I trial registered: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012

    2d agoTrial registeredOncologyPhase ISource filing (opens the source filing in a new tab)

  2. E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.momentum 70

    Phase II trial registered: Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis

    2d agoTrial registeredPhase IISource filing (opens the source filing in a new tab)

  3. Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinicomomentum 70

    Study registered, no phase assigned: Brachial Plexus Injury After Prone Positioning

    2d agoTrial registeredGrant-onlySource filing (opens the source filing in a new tab)

  4. Priothera SASmomentum 72

    Phase III trial registered: Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

    2d agoTrial registeredOncologyPhase IIISource filing (opens the source filing in a new tab)

  5. Connecta Therapeutics, S.L.momentum 74

    Phase II trial registered: Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome

    2d agoTrial registeredRare diseasePhase IISource filing (opens the source filing in a new tab)

  6. Sunnybrook Health Sciences Centremomentum 78

    Phase III trial registered: Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

    2d agoTrial registeredOncologyPhase IIISource filing (opens the source filing in a new tab)

  7. Ontario Clinical Oncology Group (OCOG)momentum 72

    Study registered, no phase assigned: Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

    2d agoTrial registeredOncologyGrant-onlySource filing (opens the source filing in a new tab)

  8. Genosco Inc.momentum 70

    Phase I trial registered: A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants

    2d agoTrial registeredPhase ISource filing (opens the source filing in a new tab)

  9. Lembasmomentum 63

    Study registered, no phase assigned: A Two-part Study of Lembas Edge Evaluating Tolerability and Postprandial Glycemic Control

    2d agoTrial registeredGrant-onlySource filing (opens the source filing in a new tab)

  10. Signal House Co., Ltd.momentum 70

    Study registered, no phase assigned: Comparison of Acoustic Variability Index (AVI) and Pulse Pressure Variation (PPV) for Predicting Fluid Responsiveness in Mechanically Ventilated Patients

    2d agoTrial registeredGrant-onlySource filing (opens the source filing in a new tab)

New to the graph

Where the week happened

  • Not yet classified394 events
  • Oncology180 events
  • Neuro85 events
  • Immunology68 events
  • Rare disease11 events

The free tier follows one therapeutic area with the full dossiers and the morning digest. Start free or compare seats.

Built from the same graph the product serves, at the moment you loaded the page. Momentum is a recency-weighted score over public filing events; every claim links to its filing. Methodology · Open the live feed · Subscribe by RSS